Table III.
<2%Eos+ <40%Neu | <2%Eos+ ≥40%Neu | ≥2%Eos+ <40%Neu | ≥2%Eos+ ≥40%Neu | P value For 4 grps* | |
---|---|---|---|---|---|
BDNF pg/ml | 9.5 (6–14.5) | 18.4 (11.2–29) | 15.4 (8–26.5) | 20 (14–39) | <0.001 |
BLC/CXCL13 pg/ml | 110±29 | 223±48 | 94±20 | 142±49 | 0.005 |
BMP4 pg/ml | 4.9±1.5 | 2.8±0.6 | 1.8±0.3 | 3.7±1.1 | 0.33 |
EGF pg/ml | 159 (108–205) | 190 (116–263) | 171 (90–212) | 199 (145–256) | 0.13 |
Eotaxin 2/CCL24 pg/ml | 0.88 (0.01–2.38) | 1.13 (0.01–6.78) | 2.39 (0.38–4.63) | 8.90 (2.5–14.1) | 0.022 |
IFNγ pg/ml | 77 (37–149) | 47 (2–128) | 108 (49–175) | 91 (23–125) | 0.11 |
IL-1β pg/ml | 104±14 | 224±56 | 76±12 | 228±65 | <0.001 |
IL-8 ng/ml | 1.5±0.1 | 2.1±0.2 | 1.6±0.2 | 1.9±0.2 | 0.017 |
IL-13 pg/ml | 91±18 | 74±9.9 | 64±12 | 81±18 | 0.55 |
LIGHT/TNFSF14 pg/ml | 36 (12–69) | 92 (36–156) | 33 (13–108) | 58 (24–184) | 0.021 |
MIP-3 α/CCL20 pg/ml | 390±41 | 781±85 | 341±52 | 668±121 | <0.001 |
PARC/CCL18 pg/ml | 6.7 (0.4–19) | 12.7 (4.7–59) | 8.3 (1.7–22) | 11 (4.6–40) | 0.037 |
TNF α pg/ml | 0.3 (0.01–1.24) | 1.1 (0.01–2.6) | 0.39 (0.01–1.9) | 0.7 (0.01–8.1) | 0.44 |
ANOVA (mean±SEM) or Kruskal-Wallis (median [25–75% quartiles])